Lifeboat Foundation

Scientists haven’t conclusively spotted any new particles since the Higgs boson, and that’s got some people worried—there are a ton of other physics puzzles remaining, many of which would require the presence of a new particle to resolve. But recently, there have been some tantalizing clues of new physics, perhaps a new particle, that many scientists are excited about.

There’s a discrepancy between theoretical and experimental calculations of the “muon magnetic moment,” or how strongly the electron’s heavier cousin behaves in a magnetic field. A newer mathematical calculation has made things even more interesting, and some particle physicists are eagerly awaiting the new results from an experiment here in the United States.

The ocean’s creatures hold secrets to some of today’s biggest medical mysteries.

Scientists have created an AI system that categorizes volcanic ash by shape, which can help researchers determine the type of eruption that caused it.

“I believe gene therapy will become a mainstay in treating, and maybe curing, many of our most devastating and intractable illnesses,” said FDA commissioner Dr Scott Gottlieb after Luxturna’s approval.

As innovative gene and cell therapies continue to make the transition from the laboratory to the clinic, they are bringing with them the promise of truly personalised medicine. The last few years have seen the regulatory approval of the first gene therapies that take a patient’s own immune cells and genetically engineer them to target cancer cells more effectively.

These chimeric antigen receptor T-cell (CAR-T) therapies now represent a rapidly growing field, with Novartis’s Kymriah, the first CAR-T therapy approved by the US Food and Drug Administration (FDA) in August 2017 for the treatment of a rare blood cancer, seen as the tip of the iceberg for this treatment class’ potential. Approval of Kite Pharma’s Yescarta, a CAR-T treatment for certain forms of non-Hodgkin lymphoma, followed just a few months later.

Continue reading “Can the gene and cell therapy revolution scale up?” »

Scientists have designed a special type of drug that helps the body eat and destroy cancerous cells.

The treatment boosts the action of white blood cells, called macrophages, that the immune system uses to gobble up unwanted invaders.

Tests in mice showed the therapy worked for aggressive breast and skin tumours, Nature Biomedical Engineering journal reports.

The advantages of flow batteries include easy scalability and long cycle life. Among its disadvantages are relatively low energy density and high component cost.

Form Energy’s use of sulfur, which is both cheap and abundant, lowers those costs dramatically.

Continue reading “The New Energy Storage Tech Gates, Bezos, Ma, and Branson Are Investing In” »

The next phase of a NASA sponsored mission to 3D print human organs and tissues in space will launch in February 2019. A 3D BioFabrication Facility (BFF) developed by nScrypt and Techshot and destined for the International Space Station (ISS) will form part of the cargo of SpaceX CRS-17.

3D printing in zero gravity

Continue reading “SpaceX mission will bring 3D bioprinter to ISS, plans to 3D print cardiac patches for damaged hearts” »

Star size comparison to the edge of expanding universe.

Nascent planet seen carving a path through the disc of gas and dust surrounding the very young star PDS70.

Nicola Davis